These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 39163678)

  • 21. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiota and IBD: Current knowledge and future perspectives.
    Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
    Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed.
    Larussa T; Abenavoli L; Fabiano G; Mancuso MA; Polimeni N; Dumitrascu DL; Luzza F
    Minerva Gastroenterol (Torino); 2021 Dec; 67(4):357-368. PubMed ID: 35040302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular Skin Disorders, Inflammatory Bowel Disease, and the Microbiome: A Systematic Review.
    Fleshner L; Roster K; Farabi B; Hirani R; Tepper K; Pitchumoni CS; Safai B; Marmon S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease.
    Ekstedt N; Jamioł-Milc D; Pieczyńska J
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases].
    Kempski J; Huber S
    Inn Med (Heidelb); 2022 Oct; 63(10):1022-1027. PubMed ID: 36044059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight.
    Wang A; Zhai Z; Ding Y; Wei J; Wei Z; Cao H
    Front Immunol; 2024; 15():1430001. PubMed ID: 39131163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease.
    Yan PG; Li JN
    Chin Med J (Engl); 2020 Apr; 133(7):834-841. PubMed ID: 32106123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.